• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组高密度脂蛋白的磷脂组成会影响其抑制内皮细胞黏附分子表达的能力。

Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.

作者信息

Baker P W, Rye K A, Gamble J R, Vadas M A, Barter P J

机构信息

University Department of Medicine, Royal Adelaide Hospital, Adelaide, Australia.

出版信息

J Lipid Res. 2000 Aug;41(8):1261-7.

PMID:10946014
Abstract

The ability of different phosphatidylcholine (PC) species to inhibit cytokine-induced expression of vascular cell adhesion molecule 1 (VCAM-1) in human umbilical vein endothelial cells (HUVECs) was investigated. PC species containing palmitoyl- in the sn-1 position and palmitoyl- (DPPC), arachidonyl- (PAPC), linoleoyl- (PLPC) or oleoyl- (POPC) in the sn-2 position were compared. These PC species were studied as components of reconstituted high density lipoproteins (rHDL) (containing apolipoprotein A-I [apoA-I] as the sole protein) or as small unilamellar vesicles (SUVs). The rHDL containing PLPC and PAPC inhibited VCAM-1 expression in activated HUVECs by 95 and 70%, respectively, at an apoA-I concentration of 16 micrometer. At this concentration of apoA-I, POPC rHDL inhibited by only 16% and DPPC rHDL did not inhibit at all. These differences could not be explained by differential binding of the rHDL to HUVECs. The same hierarchy of inhibitory activity was observed when these PC species were presented to the cells as SUVs but only when the SUVs also contained an antioxidant. It was concluded that rHDL PC is responsible for their inhibitory activity and that this varies widely with different PC species.

摘要

研究了不同磷脂酰胆碱(PC)种类在人脐静脉内皮细胞(HUVECs)中抑制细胞因子诱导的血管细胞黏附分子1(VCAM-1)表达的能力。比较了在sn-1位含有棕榈酰基且在sn-2位含有棕榈酰基(DPPC)、花生四烯酰基(PAPC)、亚油酰基(PLPC)或油酰基(POPC)的PC种类。这些PC种类作为重组高密度脂蛋白(rHDL)(仅含载脂蛋白A-I [apoA-I]作为唯一蛋白质)的成分或作为小单层囊泡(SUVs)进行研究。在apoA-I浓度为16微摩尔时,含有PLPC和PAPC的rHDL分别使活化的HUVECs中VCAM-1的表达抑制了95%和70%。在该apoA-I浓度下,POPC rHDL仅抑制了16%,而DPPC rHDL根本没有抑制作用。这些差异无法通过rHDL与HUVECs的差异结合来解释。当这些PC种类以SUVs形式呈现给细胞时,观察到了相同的抑制活性等级,但前提是SUVs也含有抗氧化剂。得出的结论是,rHDL中的PC负责其抑制活性,并且这种活性因不同的PC种类而有很大差异。

相似文献

1
Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.重组高密度脂蛋白的磷脂组成会影响其抑制内皮细胞黏附分子表达的能力。
J Lipid Res. 2000 Aug;41(8):1261-7.
2
Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.重组高密度脂蛋白抑制细胞因子诱导人脐静脉内皮细胞中血管细胞黏附分子-1表达的能力。
J Lipid Res. 1999 Feb;40(2):345-53.
3
Lack of inhibitory effect of HDL on TNFalpha-induced adhesion molecule expression in human aortic endothelial cells.高密度脂蛋白对肿瘤坏死因子α诱导的人主动脉内皮细胞黏附分子表达缺乏抑制作用。
Atherosclerosis. 2002 Dec;165(2):241-9. doi: 10.1016/s0021-9150(02)00247-2.
4
Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.磷脂在β前体载脂蛋白A-I形成和高密度脂蛋白重塑中起关键作用的证据。
Biochemistry. 2002 Oct 15;41(41):12538-45. doi: 10.1021/bi025998k.
5
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.重组高密度脂蛋白对内皮细胞中血管细胞黏附分子-1表达的抑制作用。
Biochem Biophys Res Commun. 1997 Sep 8;238(1):61-5. doi: 10.1006/bbrc.1997.7236.
6
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.重组高密度脂蛋白可抑制正常胆固醇血症兔动脉周围套环诱导的急性促氧化和促炎血管变化。
Circulation. 2005 Mar 29;111(12):1543-50. doi: 10.1161/01.CIR.0000159351.95399.50. Epub 2005 Mar 21.
7
Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.有证据表明肝脂肪酶和内皮脂肪酶对高密度脂蛋白磷脂具有不同的底物特异性。
Biochemistry. 2003 Nov 25;42(46):13778-85. doi: 10.1021/bi034990n.
8
Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins.重组高密度脂蛋白对内皮黏附分子表达抑制作用的时间序列
Atherosclerosis. 2001 Jul;157(1):23-9. doi: 10.1016/s0021-9150(00)00659-6.
9
The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.5A 载脂蛋白 A-I 模拟肽在体内和体外均具有抗炎和抗氧化作用。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):246-52. doi: 10.1161/ATVBAHA.109.200196. Epub 2009 Dec 3.
10
Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction.磷脂酰胆碱sn-2位上的长链多不饱和脂肪酸会降低重组高密度脂蛋白载脂蛋白A-I的稳定性以及卵磷脂胆固醇酰基转移酶反应的活化能。
J Lipid Res. 1997 Feb;38(2):266-75.

引用本文的文献

1
Altered HDL Phospholipid and Fatty Acid Profile in MASLD: A Possible Explanation for the Increased CVD Risk.非酒精性脂肪性肝病中高密度脂蛋白磷脂和脂肪酸谱的改变:心血管疾病风险增加的一种可能解释。
Int J Mol Sci. 2025 Jun 26;26(13):6148. doi: 10.3390/ijms26136148.
2
Atherogenic circulating lipoproteins in ischemic stroke.缺血性卒中中的致动脉粥样硬化循环脂蛋白
Front Cardiovasc Med. 2024 Dec 6;11:1470364. doi: 10.3389/fcvm.2024.1470364. eCollection 2024.
3
Expanding the Molecular Disturbances of Lipoproteins in Cardiometabolic Diseases: Lessons from Lipidomics.
拓展心血管代谢疾病中脂蛋白的分子紊乱:脂质组学的启示
Diagnostics (Basel). 2023 Feb 15;13(4):721. doi: 10.3390/diagnostics13040721.
4
Effect of Clinical and Laboratory Parameters on HDL Particle Composition.临床和实验室参数对高密度脂蛋白颗粒组成的影响。
Int J Mol Sci. 2023 Jan 19;24(3):1995. doi: 10.3390/ijms24031995.
5
Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes.从健康受试者到糖尿病前期和2型糖尿病患者,高密度脂蛋白脂质组的渐进性、定性和定量改变。
Metabolites. 2022 Jul 25;12(8):683. doi: 10.3390/metabo12080683.
6
Effect of COVID-19 on lipid profile parameters and its correlation with acute phase reactants: A single-center retrospective analysis.2019冠状病毒病对血脂谱参数的影响及其与急性期反应物的相关性:一项单中心回顾性分析。
Ann Med Surg (Lond). 2022 Jun;78:103856. doi: 10.1016/j.amsu.2022.103856. Epub 2022 May 26.
7
HDL and Endothelial Function.高密度脂蛋白与血管内皮功能。
Adv Exp Med Biol. 2022;1377:27-47. doi: 10.1007/978-981-19-1592-5_3.
8
Distinct Fatty Acid Compositions of HDL Phospholipids Are Characteristic of Metabolic Syndrome and Premature Coronary Heart Disease-Family Study.高密度脂蛋白磷脂的不同脂肪酸组成是代谢综合征和早发冠心病的特征——家族研究。
Int J Mol Sci. 2021 May 6;22(9):4908. doi: 10.3390/ijms22094908.
9
Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes.新诊断为 2 型糖尿病的正常脂质血症患者的高密度脂蛋白脂质组中动脉粥样硬化特征的早期迹象。
Int J Mol Sci. 2020 Nov 22;21(22):8835. doi: 10.3390/ijms21228835.
10
Role of long non-coding RNAs expression (ANRIL, NOS3-AS, and APOA1-AS) in development of atherosclerosis in Egyptian systemic lupus erythematosus patients.长链非编码 RNA 表达(ANRIL、NOS3-AS 和 APOA1-AS)在埃及系统性红斑狼疮患者动脉粥样硬化发展中的作用。
Clin Rheumatol. 2018 Dec;37(12):3319-3328. doi: 10.1007/s10067-018-4269-x. Epub 2018 Aug 21.